FE PnipalinvetigatorProgram Director (Las fst, mide):

BIOGRAPHICAL SKETCH

Give the folowing information for te Key personnel and consultants and collaborators. Bagin withthe principal
investigatorprogram director. Photocopy this page foreach person.

 

 

 

 

 

 

NAME, ~ POSITION TITLE
Maureen E. Hoatlin, Ph.D. Assistant Professor of Medicine
EDUCATION (Begin with baccalaureate or other inital professional education, such as nursing, ad include postdoctoral taining.) _
seu aca names; [rootiiye |, ... panne
Old Dominion University, Norfolk, VA Bs. 1975 Chemistry
Oregon Health Sciences University, Ph.D. 1993 Biochemistry
Portland, OR & Molecular Biology

 

 

 

 

 

RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present postion, st, n chronological oder, previous employment, exparience, and
hhanoes. Key personnel include the principal investigator and any other indviduais who participate in the sciatic development or execution ofthe project.

Key personnel typical wil incude all individuals with doctoral or other professional degrees, bul in some project wil include individuals atthe masters Or
‘baccalaureate lovol provided thoy contribu ina gubstanive way to the scientic development or execution ofthe projec. Include present membership on
‘any Federal Government pubic advisory committee, List chronological order, the ties, all authors, and complete reorences eal publications during the
‘past tree yoars and ta representative eater publcalions pertinent to this applicaion. OO NOT EXCEED TWO PAGES.

 

1976-1978 Analytical Chemist, LFE Environmental Laboratories, Richmond, CA

1979-1981 Analytical Chemist, SRI International, Menlo Park, CA

1981-1987 Research Associate, Department of Cell Genetics, Genentech, Inc.
San Francisco, CA

1993-present Assistant Professor, Division of Hematology and Medical Oncology,

Oregon Health Sciences University, Portland, OR

Publications:

1. Weddell GN, Yansura DG, Dowbenko DK, Hoatlin ME, Grubman MJ, Moore DM,
Kleid DG. Sequence variation in the gene for the immunogenic capsid protein
\VP1 foot-and-mouth disease virus type A. Proc Natl Acad Sci, USA 82:2618-
2622, 1985

2. Kleid DG, Dowbenko DJ, Bock LA, Hoatlin ME, Jackson ML, Patzer EJ, Shire
SJ, Weddell GN, Yansura DG, Morgan DO, McKercher PD, Moore DM.
Production of recombinant vaccines from microorganisms: vaccine for foot-and-
mouth disease virus. Microbiology 405-408, 1985.

3. Hoatlin ME, Kew OM, Renz ME. Regions of Poliovirus protein VP1 produced in
E. coli induce neutralizing antibodies. J Virol 61:1442-1447, 1987.

4. Hoatlin ME, Kozak SL, Lilly F, Chakraborti A, Kozak CA, Kabat D. Activation of
erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-
modulation by the murine Fv-2' resistance gene. Proc Nati Acad Sci, USA
87:9985-9989, 1990.

 

PHS 38 Raw 557) ‘Fom Page 6) Page FF
Neroe pages canscutvey the toro oupou he aplisen Donatus sie euch 363,30.
